|
CA2022873A1
|
|
Pharmaceutical compositions for the treatment of multiple sclerosis
|
|
AU5685473A
|
|
Improvements in or relating to organic compounds
|
|
US3686186A
|
|
Substituted isochroman or phthalan piperidenes
|
|
US3694442A
|
|
SUBSTITUTED TETRAHYDRO-1H-PYRAZOLO{8 1,2-b{9 PHTHALAZINES
|
|
US3687975A
|
|
SUBSTITUTED DIBENZ{8 a,h{9 AZULENONES AND 8-(OXA OR THIA) SUBSTITUTED DIBENZ{8 a,h{9 AZULENONES
|
|
US3694446A
|
|
5-(substituted-benzyl)-benzocycloheptenes and-1-benzthiepines
|
|
US3686173A
|
|
Substituted thiazolo(3,2-a)pyrimides
|
|
US3583976A
|
|
Nonamethyleneimines
|
|
US3583975A
|
|
Substituted octamethyleneimines
|
